RPRX

Royalty Pharma plc

Halal Rating :
Uncomfortable
See Details
Last Price $26.41 Last updated:
Market Cap $15.71b
7D Change -0.25%
1 Year Change -6.76%

Company Overview

Industries
  • Manufacturing
  • Pharmaceutical Products
  • Pharmaceutical Preparations
Exchange Nasdaq
Next Earnings Date

Royalty Pharma plc was founded in 1996 and is based in New York, New York. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Sept. 30, 2024 $564.69m $-103878000.0 - $66.51m 0.00% 64.02%
June 30, 2024 $537.27m $316.65m - $49.01m 0.00% 15.48%
March 31, 2024 $567.98m $685.98m - $44.23m 0.00% 6.45%

Company Impact

Help us evaluate Royalty Pharma plc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates